Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide

<p>Abstract</p> <p>Background</p> <p>MUC7 12-mer (RKSYKCLHKRCR), a cationic antimicrobial peptide derived from the human low-molecular-weight salivary mucin MUC7, possesses potent antimicrobial activity <it>in vitro</it>. In order to evaluate the potential t...

Full description

Bibliographic Details
Main Authors: Bobek Libuse A, Campagna Alexander N, Wei Guo-Xian
Format: Article
Language:English
Published: BMC 2007-11-01
Series:Annals of Clinical Microbiology and Antimicrobials
Online Access:http://www.ann-clinmicrob.com/content/6/1/14
id doaj-1231cfcc19cb48f3bd497a6ac45459b8
record_format Article
spelling doaj-1231cfcc19cb48f3bd497a6ac45459b82020-11-24T21:40:23ZengBMCAnnals of Clinical Microbiology and Antimicrobials1476-07112007-11-01611410.1186/1476-0711-6-14Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptideBobek Libuse ACampagna Alexander NWei Guo-Xian<p>Abstract</p> <p>Background</p> <p>MUC7 12-mer (RKSYKCLHKRCR), a cationic antimicrobial peptide derived from the human low-molecular-weight salivary mucin MUC7, possesses potent antimicrobial activity <it>in vitro</it>. In order to evaluate the potential therapeutic application of the MUC7 12-mer, we examined the effects of mono- and divalent cations, EDTA, pH, and temperature on its antimicrobial activity.</p> <p>Methods</p> <p>Minimal Inhibitory Concentrations (MICs) were determined using a liquid growth inhibition assay in 96-well microtiter plates. MUC7 12-mer was added at concentrations of 1.56–50 μM. MICs were determined at three endpoints: MIC-0, MIC-1, and MIC-2 (the lowest drug concentration showing 10%, 25% and 50% of growth, respectively). To examine the effect of salts or EDTA, a checkerboard microdilution technique was used. Fractional inhibitory concentration index (FICi) was calculated on the basis of MIC-0. The viability of microbial cells treated with MUC7 12-mer in the presence of sodium or potassium was also determined by killing assay or flow cytometry.</p> <p>Results</p> <p>The MICs of MUC7 12-mer against organisms tested ranged from 6.25–50 μM. For<it> C. albicans</it>, antagonism (FICi 4.5) was observed for the combination of MUC7 12-mer and calcium; however, there was synergism (FICi 0.22) between MUC7 12-mer and EDTA, and the synergism was retained in the presence of calcium at its physiological concentration (1–2 mM). No antagonism but additivity or indifference (FICi 0.55–2.5) was observed for the combination of MUC7 12-mer and each K<sup>+</sup>, Na<sup>+</sup>, Mg<sup>2+</sup>, or Zn<sup>2+</sup>. MUC7 12-mer peptide (at 25 μM) also exerted killing activity in the presence of NaCl, (up to 25 mM for <it>C. albicans </it>and up to 150 mM for <it>E. coli</it>, a physiological concentration of sodium in the oral cavity and serum, respectively) and retained candidacidal activity in the presence of KCl (up to 40 mM). The peptide exhibited higher inhibitory activity against <it>C. albicans </it>at pH 7, 8, and 9 than at pH 5 and 6, and temperature up to 60°C did not affect the activity.</p> <p>Conclusion</p> <p>MUC7 12-mer peptide is effective anticandidal agent at physiological concentrations of variety of ions in the oral cavity. These results suggest that, especially in combination with EDTA, it could potentially be applied as an alternative therapeutic agent for the treatment of human oral candidiasis.</p> http://www.ann-clinmicrob.com/content/6/1/14
collection DOAJ
language English
format Article
sources DOAJ
author Bobek Libuse A
Campagna Alexander N
Wei Guo-Xian
spellingShingle Bobek Libuse A
Campagna Alexander N
Wei Guo-Xian
Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
Annals of Clinical Microbiology and Antimicrobials
author_facet Bobek Libuse A
Campagna Alexander N
Wei Guo-Xian
author_sort Bobek Libuse A
title Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_short Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_full Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_fullStr Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_full_unstemmed Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide
title_sort factors affecting antimicrobial activity of muc7 12-mer, a human salivary mucin-derived peptide
publisher BMC
series Annals of Clinical Microbiology and Antimicrobials
issn 1476-0711
publishDate 2007-11-01
description <p>Abstract</p> <p>Background</p> <p>MUC7 12-mer (RKSYKCLHKRCR), a cationic antimicrobial peptide derived from the human low-molecular-weight salivary mucin MUC7, possesses potent antimicrobial activity <it>in vitro</it>. In order to evaluate the potential therapeutic application of the MUC7 12-mer, we examined the effects of mono- and divalent cations, EDTA, pH, and temperature on its antimicrobial activity.</p> <p>Methods</p> <p>Minimal Inhibitory Concentrations (MICs) were determined using a liquid growth inhibition assay in 96-well microtiter plates. MUC7 12-mer was added at concentrations of 1.56–50 μM. MICs were determined at three endpoints: MIC-0, MIC-1, and MIC-2 (the lowest drug concentration showing 10%, 25% and 50% of growth, respectively). To examine the effect of salts or EDTA, a checkerboard microdilution technique was used. Fractional inhibitory concentration index (FICi) was calculated on the basis of MIC-0. The viability of microbial cells treated with MUC7 12-mer in the presence of sodium or potassium was also determined by killing assay or flow cytometry.</p> <p>Results</p> <p>The MICs of MUC7 12-mer against organisms tested ranged from 6.25–50 μM. For<it> C. albicans</it>, antagonism (FICi 4.5) was observed for the combination of MUC7 12-mer and calcium; however, there was synergism (FICi 0.22) between MUC7 12-mer and EDTA, and the synergism was retained in the presence of calcium at its physiological concentration (1–2 mM). No antagonism but additivity or indifference (FICi 0.55–2.5) was observed for the combination of MUC7 12-mer and each K<sup>+</sup>, Na<sup>+</sup>, Mg<sup>2+</sup>, or Zn<sup>2+</sup>. MUC7 12-mer peptide (at 25 μM) also exerted killing activity in the presence of NaCl, (up to 25 mM for <it>C. albicans </it>and up to 150 mM for <it>E. coli</it>, a physiological concentration of sodium in the oral cavity and serum, respectively) and retained candidacidal activity in the presence of KCl (up to 40 mM). The peptide exhibited higher inhibitory activity against <it>C. albicans </it>at pH 7, 8, and 9 than at pH 5 and 6, and temperature up to 60°C did not affect the activity.</p> <p>Conclusion</p> <p>MUC7 12-mer peptide is effective anticandidal agent at physiological concentrations of variety of ions in the oral cavity. These results suggest that, especially in combination with EDTA, it could potentially be applied as an alternative therapeutic agent for the treatment of human oral candidiasis.</p>
url http://www.ann-clinmicrob.com/content/6/1/14
work_keys_str_mv AT bobeklibusea factorsaffectingantimicrobialactivityofmuc712merahumansalivarymucinderivedpeptide
AT campagnaalexandern factorsaffectingantimicrobialactivityofmuc712merahumansalivarymucinderivedpeptide
AT weiguoxian factorsaffectingantimicrobialactivityofmuc712merahumansalivarymucinderivedpeptide
_version_ 1725926193250697216